◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Alpa Laboratories Limited (ALPA) Financial History

Name: Alpa Laboratories Limited (ALPA) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Alpa Laboratories Limited (ALPA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Indore, India with about 457 employees. Its market capitalization is roughly ₹1 billion. In the fiscal year ended 2026-03-31, ALPA reported ₹1.0B in revenue and ₹150M in net income.

Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It offers ethical, generic, and over the counter medicines.

Interactive charts & full statements →

ALPA Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹1.0B	₹1.1B	₹1.1B	₹924M
Gross Profit	₹307M	₹356M	₹333M	₹309M
Operating Income (EBIT)	₹18M	₹34M	₹78M	₹73M
Net Income	₹150M	₹195M	₹168M	₹126M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ALPA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹239M	₹314M	₹290M	₹263M	₹191M
Gross Profit	₹32M	₹128M	₹75M	₹48M	₹64M
Operating Income (EBIT)	(₹47M)	₹34M	₹9M	(₹29M)	(₹1M)
Net Income	₹10M	₹14M	₹19M	₹1M	₹118M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ALPA Free Cash Flow History

ALPA Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹2.4B	₹2.2B	₹1.8B	₹1.7B	—
Total Liabilities	₹559M	₹512M	₹305M	₹327M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ALPA viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

6896 · Golden Throat Holdings Group Company Limited — HK$1 billion
2161 · JBM (Healthcare) Limited — HK$1 billion
BALAXI · Balaxi Pharmaceuticals Limited — ₹1 billion
1061 · Essex Bio-Technology Limited — HK$1 billion
KREBSBIO · Krebs Biochemicals & Industries Limited — ₹1 billion
VAISHALI · Vaishali Pharma Limited — ₹1 billion
MAKERSL · Makers Laboratories Limited — ₹1 billion
GUD · Knight Therapeutics Inc. — C$1 billion

← ALP All “A” companies ALPHAGEO →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.